GreenLight Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRNA and buy or sell other stocks, ETFs, and their options commission-free!About GRNA
GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets.
CEOAndrey J. Zarur, PhD
CEOAndrey J. Zarur, PhD
Employees—
Employees—
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2020
Founded2020
Employees—
Employees—
GRNA Key Statistics
Market cap45.43M
Market cap45.43M
Price-Earnings ratio-0.26
Price-Earnings ratio-0.26
Dividend yield—
Dividend yield—
Average volume185.43K
Average volume185.43K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.89
52 Week high$5.89
52 Week low$0.1768
52 Week low$0.1768
Stock Snapshot
The current GreenLight Biosciences(GRNA) stock price is $0.30, with a market capitalization of 45.43M. The stock trades at a price-to-earnings (P/E) ratio of -0.26.
During the trading day, GreenLight Biosciences(GRNA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 185.43K.
Over the past 52 weeks, GreenLight Biosciences(GRNA) stock has traded between a high of $5.89 and a low of $0.18.
Over the past 52 weeks, GreenLight Biosciences(GRNA) stock has traded between a high of $5.89 and a low of $0.18.
People also own
Based on the portfolios of people who own GRNA. This list is generated using Robinhood data, and it’s not a recommendation.